Saturday, 19 May 2012

Alan Steere

Careful investigation supports the theory that the epidemic of ignorance and corresponding lack of treatment has been perpetuated by the CDC as part of Phase II of the deadly Tuskegee Experiment.

Even worse, Phase II is being carried out by the CDC with the aid of its secretive biological warfare group. Where the Phase I experiment denied isolated patients from seeing non-CDC-approved doctors,[i] Phase II involves preventing doctors from treating patients (or even providing an accurate diagnosis--recall the Tuskegee diagnosis of syphilis as “bad blood”[ii]) outside of CDC-approved guidelines published by a medical society known as the IDSA (Infectious Disease Society of America), on an international basis.

The CDC’s own history of the Tuskegee Experiment describes how the CDC worked with prominent medical societies to gain support for the multi-decade experiment in medical malpractice:

“1969 CDC reaffirms need for study and gains local medical societies' support (AMA and NMA chapters officially support continuation of study).”

So the national agency that was supposed to be protecting the public from a deadly disease was actually in favor of letting it go untreated for experimental reasons and worked with prestigious medical societies to that end!

Tuskegee Phase II is being conducted in a similar manner, including the direct assistance of prominent medical societies through IDSA treatment guidelines[iii] enforced by CDC insiders, who are regularly found to be on the payroll of the pharmaceuticals and insurance industries--both of which can profit enormously[iv] [v] by not treating the many symptoms[vi] caused by the disease.

“One way drug companies have marketed their products is by funding the implementation of guidelines…”

--Civil Action No. 08 CA 11318 DPW

The CDC has used the non-specificity of Lyme symptoms (except for those fortunate enough to manifest the Bull’s Eye rash at the onset of infection[vii]) as an excuse to mislabel the disease and thereby prevent effective diagnosis and treatment.[viii] [ix] As Dr. Brian Fallon summarized:

“Incorrectly labeling these patients as having a functional illness, such as depression, hypochondriasis or a somatization disorder, may result in a delay in the initiation of antibiotic treatment. Such delay may lead to further dissemination of the infection, and in some cases severe disability and possibly chronic neurologic damage.”

The further dissemination of symptoms is highly profitable for pharmaceutical companies, while treating the root cause of the disease with off-patent antibiotics is not.[x]